Multilayer, degradable coating as a carrier for the sustained release of antibiotics: Preparation and antimicrobial efficacy in vitro

Journal of Controlled Release

Volumn 162, Issue 3, 2012, Pages 492-501

  Guillaume, Olivier ^a   Garric, Xavier ^a   Lavigne, Jean Philippe ^b,c   Van Den Berghe, Helene ^a   Coudane, Jean ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIV MONTPELLIER   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Antibiotic release; Antimicrobial activity; Multilayer degradable coating; Poly( caprolactone); Poly(lactide); Soft tissue prostheses

Indexed keywords

ANTI-MICROBIAL ACTIVITY; ANTIBIOTIC RELEASE; CAPROLACTONE; POLY LACTIDE; SOFT TISSUE;

ANTIBIOTICS; BIOMEDICAL EQUIPMENT; CELL CULTURE; DRUG DELIVERY; LACTIC ACID; MULTILAYERS; POLYMERS; POLYPROPYLENES; TISSUE;

PLASTIC COATINGS;

OFLOXACIN; POLYCAPROLACTONE; POLYLACTIC ACID; POLYPROPYLENE; RIFAMPICIN;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BIOFILM; CYTOTOXICITY; DRUG COATING; DRUG DELIVERY SYSTEM; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FIBROBLAST; GAMMA IRRADIATION; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROSTHESIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUSTAINED DRUG RELEASE;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICE; OFLOXACIN; POLYESTERS; POLYPROPYLENES; RIFAMPIN;

EID: 84865608473     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.08.003     Document Type: Article

References (51)

1. I.M. Rutkow Surgical operations in the United States. Then (1983) and now (1994) Arch. Surg. 132 9 1997 983 990
2. A. Bako, and R. Dhar Review of synthetic mesh-related complications in pelvic floor reconstructive surgery Int. Urogynecol. J. Pelvic Floor Dysfunct. 20 1 2009 103 111
3. G.B. Diwadkar, M.D. Barber, B. Feiner, C. Maher, and J.E. Jelovsek Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review Obstet. Gynecol. 113 2 Pt 1 2009 367 373
4. A.F. Engelsman, H.C. van der Mei, R.J. Ploeg, and H.J. Busscher The phenomenon of infection with abdominal wall reconstruction Biomaterials 28 14 2007 2314 2327
5. G.E. Leber, J.L. Garb, A.I. Alexander, and W.P. Reed Long-term complications associated with prosthetic repair of incisional hernias Arch. Surg. 133 4 1998 378 382
6. T.J. Aufenacker, D. van Geldere, T. van Mesdag, A.N. Bossers, B. Dekker, E. Scheijde, R. van Nieuwenhuizen, E. Hiemstra, J.H. Maduro, J.W. Juttmann, D. Hofstede, C.T. van Der Linden, D.J. Gouma, and M.P. Simons The role of antibiotic prophylaxis in prevention of wound infection after Lichtenstein open mesh repair of primary inguinal hernia: a multicenter double-blind randomized controlled trial Ann. Surg. 240 6 2004 955 960 (discussion 960-951)
7. T.L. Hedrick, P.W. Smith, L.M. Gazoni, and R.G. Sawyer The appropriate use of antibiotics in surgery: a review of surgical infections Curr. Probl. Surg. 44 10 2007 635 675
8. E.W. Taylor, D.J. Byrne, D.J. Leaper, S.J. Karran, M.K. Browne, and K.J. Mitchell Antibiotic prophylaxis and open groin hernia repair World J. Surg. 21 8 1997 811 814 (discussion 814-815)
9. A. Shukla, S.N. Avadhany, J.C. Fang, and P.T. Hammond Tunable vancomycin releasing surfaces for biomedical applications Small 6 21 2010 2392 2404
10. P. Wu, and D.W. Grainger Drug/device combinations for local drug therapies and infection prophylaxis Biomaterials 27 11 2006 2450 2467
11. M.C. Chen, H.F. Liang, Y.L. Chiu, Y. Chang, H.J. Wei, and H.W. Sung A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus J. Control. Release 108 1 2005 178 189
12. A.H. Maciver, A.D. McCall, R.L. Edgar, A.L. Thiesen, D.L. Bigam, T.A. Churchill, and A.M.J. Shapiron Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model Surgery 2011
13. K. Steigerwald, S. Merl, A. Kastrati, A. Wieczorek, M. Vorpahl, R. Mannhold, M. Vogeser, J. Hausleiter, M. Joner, A. Schomig, and R. Wessely The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts Biomaterials 30 4 2009 632 637
14. M. Chen, P.O. Zamora, P. Som, L.A. Pena, and S. Osaki Cell attachment and biocompatibility of polytetrafluoroethylene (PTFE) treated with glow-discharge plasma of mixed ammonia and oxygen J. Biomater. Sci. Polym. Ed. 14 9 2003 917 935
15. K. Junge, R. Rosch, U. Klinge, M. Saklak, B. Klosterhalfen, C. Peiper, and V. Schumpelick Titanium coating of a polypropylene mesh for hernia repair: effect on biocompatibility Hernia 9 2 2005 115 119
16. N. Blanchemain, T. Laurent, F. Chai, C. Neut, S. Haulon, V. Krump-konvalinkova, M. Morcellet, B. Martel, C.J. Kirkpatrick, and H.F. Hildebrand Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation Acta Biomater. 4 6 2008 1725 1733
17. A. Gomez-Alonso, F.J. Garcia-Criado, F.C. Parreno-Manchado, J.E. Garcia-Sanchez, E. Garcia-Sanchez, A. Parreno-Manchado, and Y. Zambrano-Cuadrado Study of the efficacy of Coated VICRYL Plus Antibacterial suture (coated Polyglactin 910 suture with Triclosan) in two animal models of general surgery J. Infect. 54 1 2007 82 88
18. K. Junge, R. Rosch, U. Klinge, C. Krones, B. Klosterhalfen, P.R. Mertens, P. Lynen, D. Kunz, A. Preiss, H. Peltroche-Llacsahuanga, and V. Schumpelick Gentamicin supplementation of polyvinylidenfluoride mesh materials for infection prophylaxis Biomaterials 26 7 2005 787 793
19. O. Guillaume, J.P. Lavigne, O. Lefranc, B. Nottelet, J. Coudane, and X. Garric New antibiotic-eluting mesh used for soft tissue reinforcement Acta Biomater. 7 9 2011 3390 3397
20. L. Boulanger, M. Boukerrou, C. Rubod, P. Collinet, A. Fruchard, R.J. Courcol, and M. Cosson Bacteriological analysis of meshes removed for complications after surgical management of urinary incontinence or pelvic organ prolapse Int. Urogynecol. J. Pelvic Floor Dysfunct. 19 6 2008 827 831
21. W.S. Cobb, J.B. Harris, J.S. Lokey, E.S. McGill, and K.L. Klove Incisional herniorrhaphy with intraperitoneal composite mesh: a report of 95 cases Am. Surg. 69 9 2003 784 787
22. A. Rios, J.M. Rodriguez, V. Munitiz, P. Alcaraz, D. Perez Flores, and P. Parrilla Antibiotic prophylaxis in incisional hernia repair using a prosthesis Hernia 5 3 2001 148 152
23. S. Petersen, G. Henke, M. Freitag, A. Faulhaber, and K. Ludwig Deep prosthesis infection in incisional hernia repair: predictive factors and clinical outcome Eur. J. Surg. 167 6 2001 453 457
24. H.M. Blumberg, D. Rimland, J.A. Kiehlbauch, P.M. Terry, and I.K. Wachsmuth Epidemiologic typing of Staphylococcus aureus by DNA restriction fragment length polymorphisms of rRNA genes: elucidation of the clonal nature of a group of bacteriophage-nontypeable, ciprofloxacin-resistant, methicillin-susceptible S. aureus isolates J. Clin. Microbiol. 30 2 1992 362 369
25. C. von Eiff, and G. Peters In-vitro activity of ofloxacin, levofloxacin and d-ofloxacin against staphylococci J. Antimicrob. Chemother. 38 2 1996 259 263
26. M. Michea-Hamzehpour, R. Auckenthaler, P. Regamey, and J.C. Pechere Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis Antimicrob. Agents Chemother. 31 11 1987 1803 1808
27. W. Zimmerli, A.F. Widmer, M. Blatter, R. Frei, and P.E. Ochsner Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group JAMA 279 19 1998 1537 1541
28. S.B. Levy Antibiotic resistance - the problem intensifies Adv. Drug Deliv. Rev. 57 10 2005 1446 1450
29. D.P. Konig, J.M. Schierholz, U. Munnich, and J. Rutt Treatment of staphylococcal implant infection with rifampicin-ciprofloxacin in stable implants Arch. Orthop. Trauma Surg. 121 5 2001 297 299
30. G. Schwach, J. Coudane, R. Engel, and M. Vert Ring opening polymerization of d,l-lactide in the presence of zinc metal and zinc lactate Polym. Int. 46 3 1998 177 182
31. AFNOR Evaluation biologique des dispositifs médicaux. Partie 5: Essais concernant la cytotoxicité in vitro. NF EN ISO 10993-5 1999
32. X. Garric, H. Garreau, M. Vert, and J.P. Moles Behaviors of keratinocytes and fibroblasts on films of PLA50-PEO-PLA50 triblock copolymers with various PLA segment lengths J. Mater. Sci. Mater. Med. 19 4 2007 1645 1651
33. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1-2 1983 55 63
34. D.J. Balazs, K. Triandafillu, P. Wood, Y. Chevolot, C. van Delden, H. Harms, C. Hollenstein, and H.J. Mathieu Inhibition of bacterial adhesion on PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments Biomaterials 25 11 2004 2139 2151
35. Y.J. An, and R.J. Friedman laboratory methods for studies of bacterial adhesion J. Microbiol. Methods 30 1997 141 152
36. J.M. Schierholz, and J. Beuth Implant infections: a haven for opportunistic bacteria J. Hosp. Infect. 49 2 2001 87 93
37. K. Vasilev, J. Cook, and H.J. Griesser Antibacterial surfaces for biomedical devices Expert Rev. Med. Devices 6 5 2009 553 567
38. M. Zilberman, and J.J. Elsner Antibiotic-eluting medical devices for various applications J. Control. Release 130 3 2008 202 215
39. P. Amid Classification of biomaterials and their complications in abdominal wall hernia Hernia 1 1997 15 21
40. J.M. Bellon, J. Bujan, L. Contreras, and A. Hernando Integration of biomaterials implanted into abdominal wall: process of scar formation and macrophage response Biomaterials 16 5 1995 381 387
41. H. Goldstein Selecting the right mesh Hernia 3 1999 23 26
42. O. Lefranc, Y. Bayon, S. Montanari, P. Gravagna, and M. Thérin P. von Theobald, C.W. Zimmerman, W.G. Davila, New Techniques in Genital Prolapse Surgery vol. 5 2011 275 287
43. R. Dorati, C. Colonna, M. Serra, I. Genta, T. Modena, F. Pavanetto, P. Perugini, and B. Conti gamma-Irradiation of PEGd, lPLA and PEG-PLGA multiblock copolymers. I. Effect of irradiation doses AAPS PharmSciTech 9 2 2008 718 725
44. R. Dorati, C. Colonna, C. Tomasi, I. Genta, T. Modena, A. Faucitano, A. Buttafava, and B. Conti gamma-Irradiation of PEGd, lPLA and PEG-PLGA multiblock copolymers: II. Effect of oxygen and EPR investigation AAPS PharmSciTech 9 4 2008 1110 1118
45. M. Kapischke, K. Prinz, J. Tepel, J. Tensfeldt, and T. Schulz Precoating of alloplastic materials with living human fibroblasts - a feasibility study Surg. Endosc. 19 6 2005 791 797
46. C. Langer, P. Schwartz, P. Krause, H. Mohammadi, B. Kulle, A. Schaper, L. Fuzesi, and H. Becker In-vitro study of the cellular response of human fibroblasts cultured on alloplastic hernia meshes. Influence of mesh material and structure Chirurg 76 9 2005 876 885
47. D. Weyhe, O. Belyaev, G. Buettner, K. Mros, C. Mueller, K. Meurer, G. Papapostolou, and W. Uhl In vitro comparison of three different mesh constructions ANZ J. Surg. 78 1-2 2008 55 60
48. N. Duewelhenke, O. Krut, and P. Eysel Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines Antimicrob. Agents Chemother. 51 1 2007 54 63
49. I. Javerliat, O. Goeau-Brissonniere, P. Bruneval, and M. Coggia Experimental study of a new vascular graft prebonded with antibiotic: healing, toxicity, and antibiotic retention Ann. Vasc. Surg. 21 5 2007 603 610
50. S. Bassetti, J. Hu, R.B. D'Agostino Jr.; and R.J. Sherertz In vitro zones of inhibition of coated vascular catheters predict efficacy in preventing catheter infection with Staphylococcus aureus in vivo Eur. J. Clin. Microbiol. Infect. Dis. 19 8 2000 612 617
51. R.J. Sherertz, W.A. Carruth, A.A. Hampton, M.P. Byron, and D.D. Solomon Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits J. Infect. Dis. 167 1 1993 98 106